Efficacy and safety of FOLFIRINOX in advanced cholangiocarcinoma.

被引:2
|
作者
Kim, Byung Moon
Armenio, Vincent Anthony
机构
[1] Roger Williams Med Ctr, Warwick, RI USA
[2] Boston Univ, Roger Williams Med Ctr, Providence, RI USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e15620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15620
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Safety and efficacy of modified FOLFIRINOX in patients with metastatic pancreatic cancer
    Watanabe, Kazuo
    Takahashi, Hideaki
    Umemoto, Kumiko
    Okuyama, Hiroyuki
    Hashimoto, Yusuke
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Okusaka, Takuji
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2015, 26 : 88 - 88
  • [42] Iridium therapy and endoscopic management of hilar cholangiocarcinoma.
    Gay, F
    Mokaddem, F
    Baize, M
    Cremer, M
    Vanhoutte, P
    Beauvois, S
    Van Laethem, JL
    Deviere, J
    GASTROENTEROLOGY, 1999, 116 (04) : A9 - A9
  • [43] Modulation of Fas expression: A potential therapy for cholangiocarcinoma.
    Jhala, N
    Pan, G
    Ahn, EY
    Vickers, SM
    McDonald, JM
    LABORATORY INVESTIGATION, 2001, 81 (01) : 197A - 197A
  • [44] Safety and efficacy of modified FOLFIRINOX in pancreatic cancer: A retrospective experience
    Mahaseth, Hemchandra
    Kauh, John S.
    Brutcher, Edith
    Hawk, Natalyn Nicole
    Kim, Sungjin
    Chen, Zhengjia
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Gemcitabine in the treatment of cholangiocarcinoma.: Report of four cases
    Gallardo, J
    Cabrera, E
    Rubio, B
    González, C
    Cortés, C
    REVISTA MEDICA DE CHILE, 2001, 129 (08) : 911 - 916
  • [46] Liver transplantation with neoadjuvant chemoradiotherapy for hilar cholangiocarcinoma.
    Rosen, CB
    Heimbach, JK
    Haddock, MG
    Alberts, SR
    Nyberg, SL
    Ishitani, MB
    Gores, GJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 436 - 436
  • [47] Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma
    Kazuyuki Gyoten
    Naohisa Kuriyama
    Koki Maeda
    Takahiro Ito
    Aoi Hayasaki
    Takehiro Fujii
    Yusuke Iizawa
    Akihiro Tanemura
    Yasuhiro Murata
    Masashi Kishiwada
    Shugo Mizuno
    Langenbeck's Archives of Surgery, 408
  • [48] Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma
    Gyoten, Kazuyuki
    Kuriyama, Naohisa
    Maeda, Koki
    Ito, Takahiro
    Hayasaki, Aoi
    Fujii, Takehiro
    Iizawa, Yusuke
    Tanemura, Akihiro
    Murata, Yasuhiro
    Kishiwada, Masashi
    Mizuno, Shugo
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [49] A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma
    Uson, Pedro Luiz Serrano
    Bearss, Jeremiah
    Babiker, Hani M.
    Borad, Mitesh
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (08) : 637 - 641
  • [50] Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
    Fumet, Jean-David
    Vincent, Julie
    Bengrine, Leila
    Hennequin, Audrey
    Granconato, Laura
    Palmier, Remi
    Ghiringhelli, Francois
    ANTICANCER RESEARCH, 2020, 40 (07) : 4011 - 4015